JP2024526820A5 - - Google Patents

Info

Publication number
JP2024526820A5
JP2024526820A5 JP2024502611A JP2024502611A JP2024526820A5 JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5 JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
fusion protein
composition according
actrii
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024502611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024526820A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/037479 external-priority patent/WO2023003815A1/en
Publication of JP2024526820A publication Critical patent/JP2024526820A/ja
Publication of JP2024526820A5 publication Critical patent/JP2024526820A5/ja
Pending legal-status Critical Current

Links

JP2024502611A 2021-07-19 2022-07-18 Actriiタンパク質およびその用途 Pending JP2024526820A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163223265P 2021-07-19 2021-07-19
US63/223,265 2021-07-19
PCT/US2022/037479 WO2023003815A1 (en) 2021-07-19 2022-07-18 Actrii proteins and uses thereof

Publications (2)

Publication Number Publication Date
JP2024526820A JP2024526820A (ja) 2024-07-19
JP2024526820A5 true JP2024526820A5 (enExample) 2025-07-17

Family

ID=84979535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024502611A Pending JP2024526820A (ja) 2021-07-19 2022-07-18 Actriiタンパク質およびその用途

Country Status (18)

Country Link
US (1) US20240327494A1 (enExample)
EP (1) EP4373577A4 (enExample)
JP (1) JP2024526820A (enExample)
KR (1) KR20240049857A (enExample)
CN (1) CN117957014A (enExample)
AU (1) AU2022316103A1 (enExample)
CA (1) CA3225613A1 (enExample)
CL (1) CL2024000151A1 (enExample)
CO (1) CO2024001551A2 (enExample)
CR (1) CR20240061A (enExample)
DO (1) DOP2024000016A (enExample)
EC (1) ECSP24012819A (enExample)
GE (1) GEAP202416461A (enExample)
IL (1) IL310141A (enExample)
JO (1) JOP20240010A1 (enExample)
MX (1) MX2024000829A (enExample)
PE (1) PE20240777A1 (enExample)
WO (1) WO2023003815A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021189010A1 (en) 2020-03-20 2021-09-23 Keros Therapeutics, Inc. Methods of using activin receptor type iib variants
WO2021189019A1 (en) 2020-03-20 2021-09-23 Keros Therapeutics, Inc. Activin receptor type ii chimeras and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180055822A1 (en) * 2015-03-13 2018-03-01 Repoceuticals Aps Melatonin for Preventing and Treating Radiation Cystitis
EP3380121B1 (en) * 2015-11-23 2023-12-20 Acceleron Pharma Inc. Actrii antagonist for use in treating eye disorders
DK3496739T3 (da) * 2016-07-15 2021-05-10 Acceleron Pharma Inc Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension

Similar Documents

Publication Publication Date Title
JP2017538395A5 (enExample)
JP2024526820A5 (enExample)
US9700595B2 (en) Liquid formulation of a fusion protein comprising TNFR and Fc region
JP2016534052A5 (enExample)
JP2023040169A5 (enExample)
JP2021534220A5 (enExample)
JP2016536369A5 (enExample)
JP2008500373A5 (enExample)
RU2007119989A (ru) Композиции, слитые конструкции и конъюгаты plad домена
JP2018501201A5 (enExample)
JP2023545707A5 (enExample)
JP2021514354A5 (enExample)
US5660826A (en) Therapeutic sepsis treatment using antagonists to PTHrP
JP2025518227A (ja) mazdutideを使用する治療方法
JP2017524675A5 (enExample)
CN112390884B (zh) Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用
JP2023526218A5 (enExample)
FI114011B (fi) Suonensisäiseen käyttöön tarkoitetun immunoglobuliinin käyttö farmaseuttisen koostumuksen valmistamiseksi syöpäsairauksien hoitamiseksi
JP2023531496A5 (enExample)
JPH11512747A (ja) 造血幹細胞の動員方法
JP2024519904A5 (enExample)
CN105521485A (zh) 脱铁乳铁蛋白组合物及其用于治疗病毒性丙型肝炎的方法
IL323508A (en) Methods and uses for treating nausea and vomiting
JP2023537115A5 (enExample)
JP2024546129A5 (enExample)